Senior Research Associate / Scientist, Lipid Nanoparticle Discovery
Addition Therapeutics
Senior Research Associate / Scientist, Lipid Nanoparticle Discovery
Addition Therapeutics
Develops non-viral RNA therapeutics for diseases
Company
Addition Therapeutics is at the forefront of biotechnology innovation and is building the next generation of gene therapy using our proprietary PRINT™ (Programmable RNA-guided Integration Technology) platform. PRINT™ redefines genetic medicine by enabling development of RNA-only therapeutics capable of inserting any genetic element into specific safe harbor sites within the genome. Operating from state-of-the-art labs in South San Francisco, we are a Series A-stage company with programs across rare and common diseases.
The Role
Addition Therapeutics is currently seeking a highly motivated contract SRA / Scientist, Lipid Nanoparticle (LNP) Discovery to support the development and production of lipid nanoparticle formulations for the delivery of nucleic acid therapeutics. The ideal candidate will join the Addition Therapeutics LNP Discovery Team and will be responsible to design, produce, characterize, and optimize LNP formulations to support preclinical research and the development of the company’s novel gene-supplement technology.
The successful candidate will contribute to the continuous improvement of Addition Therapeutics’ delivery platform and work across multiple programs to produce formulations that support the company’s in vitro and in vivo preclinical studies. This hands-on role requires strong technical expertise in LNP formulation and production, sound scientific judgment, attention to detail, and the ability to work effectively in a highly collaborative, fast-paced environment. This position is based in South San Francisco.
About The Role
What We're Looking For
Work Environment and Travel Requirements
This role involves on-site work and travel to contracted research organization (CRO) facilities. Access to these facilities requires completion of certain health screenings and medical clearances, including proof of MMR immunity and TB screening, as required by the facility. Candidates should be comfortable completing these requirements if selected for the position.
Compensation
This is a contract position with an estimated hourly rate of $65-$75. Exact compensation may vary based on skills and experience.
We are an Equal Opportunity employer and will consider all qualified applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status.
Develops non-viral RNA therapeutics for diseases
Addition Therapeutics develops genomic medicines using a non-viral, all-RNA approach delivered by LNPs (lipid nanoparticles) through its PRINT platform. Its product strategy focuses on creating one-time, durable therapies for chronic and rare diseases, instead of traditional multi-dose treatments. The platform enables RNA therapies to be packaged and delivered without viral vectors, aiming for safer delivery and longer-lasting effects. Compared with others, its PRINT-based, non-viral method aims to offer stronger safety profiles and durable responses, along with a pipeline of therapeutics that can be clinically meaningful for patients with difficult-to-treat conditions. The company’s goal is to realize the transformative potential of genomic medicine by delivering safe, durable, one-time treatments that address unmet medical needs in chronic and rare diseases.
Explore more opportunities at Addition Therapeutics